Srinivas Kaza, MD
Otolaryngology · Canandaigua, NYNPI 1679597652
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.8%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Aerin Medical Inc. at 46.8% of the total.
Across 36 payments — averaging $114.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$2K
- Medtronic$1K
- Intuitive Surgical$277
- Smith+Nephew$218
- Stryker$210
- Optinose US, Inc.$136
- plus $172 from 4 others
What the payments were for
- Travel & lodging$1,60039%
- Food & beverage$2,38958%
- Entertainment$1454%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 15 | $1,936 |
| Medtronic(2 entities) | 10 | $1,186 |
| Intuitive Surgical | 2 | $277 |
| Smith+Nephew | 2 | $218 |
| Stryker | 2 | $210 |
| Optinose US, Inc. | 1 | $136 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $125 |
| Boston Scientific | 1 | $18 |
| Sanofi | 1 | $17 |
| Xoran Technologies LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,402
- StealthStation$553
- RHINAER STYLUS$368
- PTEYE PARATHYROID DETECTION SYSTEM$227
- Da Vinci Surgical System$210
- FUSION$163
- XPRESS LOPROFILE$160
- Halo$150
- TULA$150
- Xhance$136
- NEFFY$125
How this compares
$4,134 in reported general payments places this provider in the 75th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $44,641 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 48 | $7,296 |
| Sodium ChlorideSodium Chloride Irrig Solution | 114 | $7,029 |
| SynthroidLevothyroxine Sodium | 86 | $6,541 |
| Mometasone Furoate | 92 | $5,824 |
| Azelastine Hcl | 200 | $5,721 |
| Ipratropium Bromide | 151 | $3,952 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 30 | $3,422 |
| Levothyroxine Sodium | 270 | $2,887 |
| SingulairMontelukast Sodium | 11 | $2,838 |
| Levocetirizine Dihydrochloride | 194 | $2,047 |
| Fluticasone Propionate | 122 | $1,752 |
| Famotidine | 86 | $1,282 |
| Montelukast Sodium | 118 | $965 |
| Liothyronine Sodium | 33 | $923 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Canandaigua
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
- Dennis KrausNew York$159K
- Nitin BhatiaWhite Plains$120K
- Sveta KarelskyRochester$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.